Reducing human suffering by detecting cancer earlier with patented technology
BioCurex's RECAF(tm) marker is found in all types of major cancers
  • Demo Video
  • Private Messages
  • Edit My Profile
  • View/Edit Portfolio

Widget

Add BioCurex widget to your own site or blog

Email Updates

Search

AGORACOM News Flash

ATTENTION AGORACOM MEMBERS - WE'RE GROWING AGAIN & YOU'RE INVITED:

Hey, gang.  We're really proud to announce another great tool for our members and all online investors.  Here's the news:

1.  AGORACOM Launches Online Conferences  (Full Story)

2.  AGORACOM Announces 1st Conference.  The AGORACOM Online Gold & Commodities Conference  (Full Story).  December 3-4.  Save The Date!

Looking forward to your feedback.  Thanks and have a great day!

Regards,
George, Paul et al.

 

Message: Cure

Generic_profile
Rank: [?]
Mail Room
Points: [?]
75
Rating: [?]
Votes: 3 Score: 2.6
  • Currently 2.7/5 Stars.
Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Cure

posted on Jun 28, 09 06:33PM

My sister ( a two time breast cancer survivor) handed me this magazine yesterday to check out. Titled "CURE" it is published in association with the American Cancer Society. The periodical contains the latest info on cancer updates, research, and education. there was even an article on markers. The website for the current issue is http://www.curetoday.com/index.cfm/fuseaction/magazine.show/id/15

I searched the archives online and found no reference to RECAF or Biocurex. So the thought occurred to me to email the editor ( editor@curetoday.com ) and give them some info on BOCX. Maybe it will spark their interest to write an article. Maybe a few of us should email them to get noticed.

New Message

Please login to post a reply

AGORACOM Quick Tips

Start A New HUB. Control. Quality. Refreshing. ... Start One Now

Executive Address

Bocx-ricardo-ea
Dr. Ricardo Moro
President & CEO
November 27, 2008

Dr. Moro discusses Biocurex's latest developments

View Broadcast

Stock Quote